Michael J. Brooks - 29 May 2025 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
President
Signature
/s/ Peter J. Weiler, Attorney-in-Fact for Michael J. Brooks
Issuer symbol
EDSA
Transactions as of
29 May 2025
Net transactions value
$0
Form type
4
Filing time
02 Jun 2025, 21:18:41 UTC
Previous filing
04 Aug 2023
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brooks Michael J President C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA /s/ Peter J. Weiler, Attorney-in-Fact for Michael J. Brooks 02 Jun 2025 0001779126

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award $0 +207,201 +1173% $0.000000 224,870 29 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 142,592 shares shall vest in equal proportions over eighteen (18) months, commencing on the grant date and (ii) 64,609 shares vest in equal proportions over thirty-six (36) months, commencing on the grant date.
F2 Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.

Remarks:

Exhibit 24 - Power of Attorney